{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:25:34Z","timestamp":1776986734676,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.ejphar.2004.10.010","type":"journal-article","created":{"date-parts":[[2004,11,3]],"date-time":"2004-11-03T17:09:28Z","timestamp":1099501768000},"page":"223-233","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity"],"prefix":"10.1016","volume":"504","author":[{"given":"Flora","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mennuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziano","family":"Zanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Makovec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.10.010_bib1","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1164\/ajrccm.157.6.mar-2","article-title":"Pharmacology of leukotriene receptor antagonists","volume":"157","author":"Aharony","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2004.10.010_bib2","first-page":"420","article-title":"SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions","volume":"284","author":"Barnette","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.10.010_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bjp.0702779","article-title":"Anti-spasmogenic activity of isoenzyme-selective phosphodiesterase inhibitors in guinea-pig trachealis","volume":"128","author":"Bernareggi","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.10.010_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"75","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2004.10.010_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0091-6749(91)90160-P","volume":"88","author":"Bradley","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2004.10.010_bib6","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1021\/jm960088k","article-title":"Modulators of leukotriene biosynthesis and receptor activation","volume":"39","author":"Brooks","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2004.10.010_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0014-2999(02)02232-X","article-title":"Pharmacological profile of MEN91507, a new Cys\u2013LT1 receptor antagonist","volume":"451","author":"Cabr\u00e9","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2004.10.010_bib8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.bjp.0701636","article-title":"Pharmacological characterization of the cysteinyl\u2013leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro","volume":"123","author":"Capra","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.10.010_bib9","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJM198406213102502","article-title":"Peptide leukotriene release after antigen challenge in patients sensitive to ragweed","volume":"310","author":"Creticos","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2004.10.010_bib10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/thx.48.12.1205","article-title":"Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects","volume":"48","author":"Dahlen","year":"1993","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2004.10.010_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/phrs.1998.0461","article-title":"Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update: Part II. clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma","volume":"40","author":"Devillier","year":"1999","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2004.10.010_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","article-title":"Treatment of asthma with drugs modifying the leukotriene pathway","volume":"340","author":"Drazen","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2004.10.010_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.bjp.0701580","article-title":"The effects of a novel sulphidopeptide leukotriene antagonist, BAY x7195, against elicited bronchoconstriction in the anesthetized guinea-pig","volume":"123","author":"Francis","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.10.010_bib14","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/0006-2952(92)90160-K","article-title":"Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?","volume":"43","author":"Giembycz","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.10.010_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0165-6147(96)10044-4","article-title":"Cysteinyl\u2013leukotriene receptors in the human lung: what's new?","volume":"17","author":"Gorenne","year":"1996","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2004.10.010_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM198302243080807","article-title":"Effects of leukotriene D on the airways in asthma","volume":"308","author":"Griffin","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2004.10.010_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/290343a0","article-title":"Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro","volume":"290","author":"Hanna","year":"1981","journal-title":"Nature (London)"},{"key":"10.1016\/j.ejphar.2004.10.010_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF01972724","article-title":"The effects of anti-inflammatory and antiallergic drugs on the release of IL-1 beta and TNF-alpha in the human whole blood assay","volume":"39","author":"Hartman","year":"1993","journal-title":"Agents Actions"},{"key":"10.1016\/j.ejphar.2004.10.010_bib19","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","article-title":"Characterization of human cysteinyl\u2013leukotriene 2 receptor","volume":"275","author":"Heise","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2004.10.010_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0005-2744(76)90296-5","article-title":"Human blood platelets 3\u2032:5\u2032-cyclic nucleotide phosphodiesterase","volume":"429","author":"Hidaka","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2004.10.010_bib21","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1067\/mai.2003.25","article-title":"Role of cysteinyl\u2013leukotrienes in airway inflammation, smooth muscle function, and remodeling","volume":"111","author":"Holgate","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2004.10.010_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/y95-028","article-title":"Pharmacology of montelukast sodium (Singulair\u2122), a potent and selective leukotriene D4 receptor antagonist","volume":"73","author":"Jones","year":"1994","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.ejphar.2004.10.010_bib24","first-page":"557","article-title":"In vivo pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist","volume":"243","author":"Krell","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.10.010_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1164\/ajrccm\/141.4_Pt_1.978","article-title":"The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist","volume":"141","author":"Krell","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2004.10.010_bib25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0091-6749(96)80002-9","article-title":"Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial","volume":"98","author":"Liu","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2004.10.010_bib27","unstructured":"Makovec, F., Peris, W., Rovati, L.C., 2001. Tyrosine Derivatives with Anti-leukotriene Activity. N.PCT\/EP01\/01315 (7\/2\/2001)."},{"key":"10.1016\/j.ejphar.2004.10.010_bib26","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJM199012203232504","article-title":"Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist","volume":"323","author":"Manning","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2004.10.010_bib28","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/thx.53.10.835","article-title":"Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma","volume":"53","author":"Nakamura","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2004.10.010_bib29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0091-6749(96)70086-6","article-title":"Effects of montelukast (MK-0476), a new potent cysteinyl\u2013leukotriene (LTD4) receptor antagonist, in patients with chronic asthma","volume":"98","author":"Reiss","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2004.10.010_bib30","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1164\/ajrccm.155.6.9196086","article-title":"Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics","volume":"155","author":"Roquet","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2004.10.010_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation","volume":"220","author":"Samuelsson","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2004.10.010_bib32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/ajrccm.150.3.8087328","article-title":"Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma","volume":"150","author":"Spector","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2004.10.010_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-126-3-199702010-00001","article-title":"Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial","volume":"126","author":"Suissa","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2004.10.010_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/thx.46.7.512","article-title":"Phosphodiesterase inhibitors: new opportunities for the treatment of asthma","volume":"46","author":"Thorphy","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2004.10.010_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2222.2003.01615.x","article-title":"Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma","volume":"33","author":"Wu","year":"2003","journal-title":"Clin. Exp. Allergy"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904011616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904011616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T11:51:48Z","timestamp":1549108308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904011616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0014299904011616"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.10.010","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}